Esperion Stock Analysis

ESPR -  USA Stock  

USD 5.79  0.39  6.31%

The latest price spike of Esperion Theraptc could raise concerns from retail investors as the firm is trading at a share price of 5.79 on 884,584 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in June. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.18. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Esperion Theraptc partners.
Continue to Investing Opportunities.
The Esperion Theraptc stock analysis report makes it easy to digest most publicly released information about Esperion Theraptc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Esperion Stock analysis module also helps to analyze the Esperion Theraptc price relationship with some important fundamental indicators such as market cap and management efficiency.

Esperion Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 11.69. Esperion Theraptc had not issued any dividends in recent years. The entity had 1:6 split on the 11th of June 2013. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. To learn more about Esperion Theraptc call Timothy Mayleben at 734 887 3903 or check out

Esperion Theraptc Quarterly Cost of Revenue

7.12 Million


Esperion Theraptc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Esperion Theraptc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Esperion Theraptc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Esperion Theraptc is way too risky over 90 days horizon
Esperion Theraptc appears to be risky and price may revert if volatility continues
Esperion Theraptc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 78.45 M. Net Loss for the year was (269.11 M) with loss before overhead, payroll, taxes, and interest of (41.74 M).
Esperion Theraptc currently holds about 259.33 M in cash with (263.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.13.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Sale by Warren Eric of 196 shares of Esperion Theraptc

Esperion Theraptc Upcoming and Recent Events

Earnings reports are used by Esperion Theraptc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Esperion Theraptc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report22nd of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End22nd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Esperion Largest EPS Surprises

Earnings surprises can significantly impact Esperion Theraptc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Esperion Theraptc SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Esperion Theraptc prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Esperion Theraptc investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Esperion Theraptc specific information freely available to individual and institutional investors to make a timely investment decision.
17th of May 2022
Unclassified Corporate Event
3rd of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
28th of April 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
15th of March 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
1st of March 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
22nd of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
14th of February 2022
Unclassified Corporate Event
11th of February 2022
Unclassified Corporate Event

Esperion Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Esperion Theraptc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Esperion Theraptc backward and forwards among themselves. Esperion Theraptc's institutional investor refers to the entity that pools money to purchase Esperion Theraptc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Wasatch Advisors IncCommon Shares8.1 M37.8 M
Deep Track Capital LpCommon SharesM27.8 M
Pentwater Capital Management LpDebt46.4 M24.2 M
Vanguard Group IncCommon Shares4.5 M20.8 M
Meditor Group LtdCommon Shares4.5 M20.7 M
Bellevue Group AgCommon Shares4.3 M19.9 M
Blackrock IncCommon Shares3.8 M17.5 M
Platinum Investment Management LtdCommon Shares2.7 M12.6 M
Note, although Esperion Theraptc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Esperion Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 385.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Esperion Theraptc's market, we take the total number of its shares issued and multiply it by Esperion Theraptc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Esperion Profitablity

Esperion Theraptc's profitability indicators refer to fundamental financial ratios that showcase Esperion Theraptc's ability to generate income relative to its revenue or operating costs. If, let's say, Esperion Theraptc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Esperion Theraptc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Esperion Theraptc's profitability requires more research than a typical breakdown of Esperion Theraptc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Investment(270.60) (291.96) 
Return on Average Assets(0.92) (1.00) 
Return on Average Equity 0.95  0.88 
Return on Invested Capital(0.45) (0.48) 
Return on Sales(2.84) (2.92) 

Management Efficiency

The entity has return on total asset (ROA) of (36.31) % which means that it has lost $36.31 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (260.79) %, meaning that it created substantial loss on money invested by shareholders. Esperion Theraptc management efficiency ratios could be used to measure how well esperion theraptc manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/24/2022, Return on Investment is likely to drop to -291.96. In addition to that, Return on Average Assets is likely to drop to -1. Esperion Theraptc Goodwill and Intangible Assets are relatively stable at the moment as compared to the past year. Esperion Theraptc reported last year Goodwill and Intangible Assets of 64,400. As of 05/24/2022, Asset Turnover is likely to grow to 0.38, while Total Assets are likely to drop slightly above 313.6 M.
Last ReportedProjected for 2022
Book Value per Share(6.81) (7.35) 
Enterprise Value over EBIT(2.00) (2.16) 
Enterprise Value over EBITDA(2.32) (2.51) 
Price to Book Value(0.74) (0.76) 
Tangible Assets Book Value per Share 13.20  11.67 
Enterprise Value515.5 M737.7 M
Tangible Asset Value381.5 M313.5 M

Technical Drivers

As of the 24th of May, Esperion Theraptc shows the Downside Deviation of 4.89, coefficient of variation of 646.7, and Mean Deviation of 4.14. Esperion Theraptc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Esperion Theraptc, which can be compared to its rivals. Please confirm Esperion Theraptc standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Esperion Theraptc is priced favorably, providing market reflects its regular price of 5.79 per share. Given that Esperion Theraptc has jensen alpha of 0.9223, we urge you to verify Esperion Theraptc's prevailing market performance to make sure the company can sustain itself at a future point.

Esperion Theraptc Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Mid-point over period is an average of Esperion Theraptc highest and lowest values attained during the given period.

Esperion Theraptc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Esperion Theraptc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Esperion Theraptc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Esperion Theraptc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Esperion Theraptc Predictive Daily Indicators

Esperion Theraptc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Esperion Theraptc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Esperion Theraptc Forecast Models

Esperion Theraptc time-series forecasting models is one of many Esperion Theraptc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Esperion Theraptc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Esperion Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Esperion Theraptc stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Esperion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Esperion Theraptc. By using and applying Esperion Stock analysis, traders can create a robust methodology for identifying Esperion entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(48.01) (51.81) 
EBITDA Margin(2.83) (2.91) 
Gross Margin 0.82  0.83 
Profit Margin(3.43) (3.52) 
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 218 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Esperion Theraptc to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Holdings Now


Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module
Continue to Investing Opportunities. Note that the Esperion Theraptc information on this page should be used as a complementary analysis to other Esperion Theraptc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Esperion Stock analysis

When running Esperion Theraptc price analysis, check to measure Esperion Theraptc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Theraptc is operating at the current time. Most of Esperion Theraptc's value examination focuses on studying past and present price action to predict the probability of Esperion Theraptc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Esperion Theraptc's price. Additionally, you may evaluate how the addition of Esperion Theraptc to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Esperion Theraptc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Theraptc. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Theraptc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Esperion Theraptc is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Theraptc's value that differs from its market value or its book value, called intrinsic value, which is Esperion Theraptc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Theraptc's market value can be influenced by many factors that don't directly affect Esperion Theraptc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Theraptc's value and its price as these two are different measures arrived at by different means. Investors typically determine Esperion Theraptc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Theraptc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.